Skip To The Main Content
Committee & Speaker Biographies

Committee & Presenter Biographies

2022 PDA Robotics and Automation Conference

16-17 May 2022

  • Martin Dueblin

    One One Eleven

    Martin Düblin is a mechanic and process engineer and highly experienced in the field of the life science industry, infrastructure and health care community. During more than 25 years he has been involved in many major strategic projects in Europe and Asia for laboratories, pilot scale installations, production, office buildings, hospitals, education, warehouse, energy / utilities and waste management. He was responsible for consulting, project management, program management, controlling, design and engineering, documentation, validation and qualification. He has undertaken all aspects in the project initiation phase, through the execution till handing over and hold key roles for critical phases. Due to his wide and skilled knowledge of life science matters he was further active for business development of various suppliers within Europe and USA. Several products and brands have been launched under his responsibility. Since several years he is well involved in all kind of technical «revolutions» as with robotic and AI offering high quality products and global competitiveness, in his role as specialist for various life science companies.

  • Toni Manzano

    Toni Manzano


    Toni is the co-founder and CSO of Aizon, a cloud company that provides big data and AI SaaS platform for the Biotech and Pharma industry. He is also co-chair of the Biomanufacturing IG and co-chair of the CPV of the Future initiative at the PDA, Lead of the AI in Operations team for the AI Xavier University and he teaches AI subjects at the Universities (UAB and OBS), member of the Science Experts in the Spanish Parliament on big data and artificial intelligence topic and collaborator with the UN in AI subjects. He has written numerous articles in the Pharma field and holds a dozen international patents related to the encryption, transmission, storage and processing of large volumes of data for regulated environments in the cloud. Toni is Physicist, Master in Information and Knowledge Society and post graduated in quality systems for manufacturing and research pharmaceutical processes.

  • Margaret Corduff

    Margaret Corduff

    Odyssey VC

    Mag has almost 20 years’ experience working across Quality Assurance, Regulatory Compliance and Quality Control within regulated medical device, pharmaceutical and biotechnology industries. Mag holds a BSC in Industrial Microbiology from University College Dublin, an MSC in Pharmaceutical Quality Assurance & Regulation from TU Dublin and is lead auditor trained to both ISO 9001 & ISO 27001. Mag is also a member of different working groups / committees within the Parenteral Drug Association.

  • Dieter Bachmann

    Bachmann Dieter, PhD

    Janssen J&J

    Dieter is Dir. Aseptic Manufacturing at J&J's corporate Sterility Assurance group with a main responsibility for providing standardization, science and education across J&J in the field of aseptic processing technologies. He is a Pharmacist by training with 30+ years of experience and holds a PhD in Pharmaceutical Formulation Technologies. Dieter has worked with small family-owned companies as well as in global business. Since joining Johnson & Johnson in 1998 he held several positions in R&D, Operations and Quality of J&Js Pharma and Medical Device franchises. Alongside business Dieter always engaged in associations work. For 10 years Dieter used to work as a Swiss national delegate on developing monographs for the European Pharmacopeia (EP) at EDQM in Strassburg. He is a frequent presenter and active member of PDA and ISPE. Dieter engages at the German DIN/NA063 and ISO TC198. Since 2019 Dieter is the global convenor for ISO TC198/WG9 Aseptic Processing.

  • Yvonne Duckworth

    Yvonne Duckworth


    Yvonne Duckworth, PE is a registered Automation Engineer at CRB with 30+ years of experience working in the pharmaceutical and biotech industries. Ms. Duckworth is also an Industry 4.0 subject matter expert (SME) providing Digitalization consulting for the pharma and biotech industries. With a strong background in both technical design and project management, her areas of expertise include process control system design including PLC and DCS based platforms, network infrastructure design, as well as leading Industry 4.0 and Digitalization initiatives. Ms. Duckworth is a frequent speaker at pharmaceutical conferences both nationally and internationally, featuring Automation and Digitalization.  She has also presented as a guest speaker for local universities specializing in biotechnology.  Ms. Duckworth has written multiple magazine articles featuring Pharma 4.0/Industry 4.0. Ms. Duckworth has a Bachelor of Science in Electrical Engineering from Widener University and a Master of Business Administration from Rider University. She is an active member of the International Society for Pharmaceutical Engineering (ISPE), Women in Pharma (WIP), International Society of Automation (ISA), and Women in Bio (WIB).  She is also a co-chair of the ISPE Pharma 4.0 Holistic Control Strategy/Digital Maturity Special Interest Group (SIG).

  • Christine Eckardt

    Christine Eckardt

    Johnson & Johnson

    Christine Eckardt is a Pharmaceutical Engineer with nearly 20 years of experience in the Pharmaceutical, Biotech and Cosmetics industry. She is a Senior Manager Design and Engineering (EMEA) with Johnson & Johnson. Her main technical focus throughout the whole career have been on Fill/Finish, Packaging, Clean Rooms incl. HVAC & Robotics. Christine always has worked in a very broad sector and always had the chance to grab on something new - staying curious the whole life long is a very enjoyable fact. Through this, her passion for robotics has grown in recent years, as she has had the opportunity to get more and more involved in the robotics space and it became an important theme for her. Christine’s catch phrase is “everything a human hand is able to do a robot can do”. There are no limits to what is possible, if we can get people more open to new technologies.

  • Reyk Horland

    Reyk Horland, PhD


    Since 2010, Reyk has been actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. He currently holds the position of Head of Business Development at TissUse.

    Prior to TissUse, Reyk studied Biotechnology at the Technische Universität Berlin and specialized in Medical Biotechnology. During his academic career he was involved in various tissue engineering programs, all with a focus on commercialisation of the respective products.

  • Florian Huber

    Florian Huber


    Florian started nearly a decade ago as an engineer in the field of production technology and Industry 4.0. His interest in this field was mostly focused on automation and machine learning. When moving to the field of life science around six years ago he used this experience to develop the first fully automated Multi-Organ-Chip platform. Today, he is responsible for the software development team at TissUse including the fields of robotics and data science.  His passion is to bring the newest developments in Machine Learning and Artificial Intelligence to the field of life sciences and laboratory automation.

  • Marilyn Romieux

    Marilyn Romeux

    Merck KGaA

    Marilyn Romieux is the Strategy and Execution Director of the Pharma Analysis & QC segment for Merck KGaA. She started as an R&D Scientist in the field of rapid microbiology before moving to a Marketing role where she created a new range of application services designed to support users in developing and implementing microbiology QC methods. Her later assignment as Head of Technical Marketing and Scientific Liaison includes employee education, customer training and application development. With an extensive knowledge of microbiology QC and nearly two decades in serving the pharma industry, she took the role of Strategic Marketing Director for the microbiology QC business in 2020, where one of her assignments was leading the marketing of Merck’s Robotics & Automation offer. She expanded her scope to all Science and Lab Solutions businesses of Merck in January 2022. She graduated in Cell Biology and Biochemistry from the University of Strasbourg, France, and earned her Master’s degree in Life Sciences from AgroParisTech in Paris, France.

  • Philipp Schmid

    Philipp Schmid


    Philipp Schmid is Head Research and Business Development for Industry 4.0 & Machine Learning at CSEM. He holds an engineering degree in Microtechnology focused on Robotics and a MAS in Management, Technology and Economics from ETH Zürich. Before joining CSEM he worked in several industrial companies including Roche and spent one year as research fellow at the ICT Robotics group (CSIRO) in Australia. From his experience as Section Head he gained a profound expertise in delivery of advanced solutions in robotics and machine learning to industry. Now he manages the research, development and industrialization of new technologies. He is member of various expert committees such as SATW and Data Innovation Alliance, works as an innovation coach and is co-founder of the Digital Innovation Hub for Robotics & Artificial Intelligence.

  • Kevin Smyth

    Kevin Smith


    Kevin Smyth is a chartered biochemical engineer with over 30 years’ global experience in the design of biopharmaceutical manufacturing facilities. He has led multiple large molecule biologics, vaccines, and sterile fill-finish projects, from the development of project scope, front-end planning, feasibility studies to detailed design. Kevin has extensive biopharmaceutical process design experience, including facility scoping, layout development, regulatory compliance, high containment of toxins and potent biologics , technology evaluation, safety reviews (Hazops/FMEAs), PFD/P&ID design and equipment selection. Kevin is an active committee member of the PDA and ISPE Ireland Committees and has regularly chaired, presented at and organised technical seminars in Ireland/Europe for these organisations. Kevin possesses excellent technical knowledge and has a passion for innovation in design.

  • Oisin Curran

    Oisin Curran

    Odyssey VC

    Oisín has been working in life sciences for more than 2 decades. During this time, he has held leading roles in transforming Life Sciences across multiple business areas including regulatory and compliance, digital and connected health. Oisín has extensive experience in Life Sciences Applications, GxP Cloud Integration, IoT and Healthcare system deployment.

  • Yannick Danguel

    Yannick Danguel

    Eli Lilly

    Yannick is Senior Project Leader for Eli Lilly France based in Strasbourg, He earned a bachelor’s degree in mechanical engineering in 2000’s at the national Technical University in Strasbourg. Worked first as a maintenance engineer in the cosmetics industry then move to Lilly in the Engineering Division in 2004. With 20 years of experience in the fields of engineering, maintenance, and reliability in Filling & Device Packaging space. Now since 2 years, Project lead for Sorting & Inspection Area.

  • Claude Dedry

    Claude Dedry


    Claude Dedry is the CEO of salamanderU. Claude is Industrial Pharmacist by background and is graduate in master's degree in management. Claude started his carreer in Glaxo SmithKline Biologicals for whom he took first the responsibility of the Supplier Quality Assurance group. After, as Vaccine Manufacturing Manager, he was project manager in Hungary for the construction and the starting up of a vaccine manufacturing plant; as Packaging Director, he was responsible for the packaging operations of the whole vaccines portfolio; as International Quality Assurance Director, he implemented the QMS of GSK Corporate within the international vaccine sites. Since 2003, he is senior consultant in the field of industrial and clinical operations related to injectable products. As consultant, he worked for vaccine manufacturers and he has also been involved in several projects as CMC expert in ATMP. From 2017, Claude has been the CEO of salamanderU which commercializes innovative digital and technical tailor made solutions serving the increase of the operational efficiency of their pharma customers. With SmartReg their proprietary MES based on Tech To Speech and Voice Recognition interfaces, salamanderU offers the only vocal digital solution that really allows and facilitates the real-time data recording and traceability in pharmaceutical operations.

  • Richard Denk

    Richard Denk

    Richard Denk is working at the company SKAN AG, headquartered in Allschwil/Switzerland in the position Senior Consultant Aseptic Processing & Containment. Richard was member of the PDA Isolator Expert Group and publisher of the PDA Paper “Isolator Surfaces and Contamination Risk to Personnel and Patient”. Furthermore, Richard is Member of the PDA Advisory Board for ATMPs, Richard is Member of the ISO TC 198 WG-9 Aseptic Isolator Group. Richard founded 11 years ago the Containment expert group of the ISPE D / A / CH. The Containment Group published the Containment Manual Richard was responsible for in September 2021 Richard has spent more than 30 years with the subject production of aseptic processing and highly active / highly hazardous substances and has developed the containment pyramid.
  • Rupert Depner

    Rupert Depner

    Körber Pharma Inspection GmbH

    Mr. Depner visited the University of Applied Science in Kempten and graduated in 2010 as Dipl.-Ing. FH (economic engineering). 2010 he started as a project engineer at Seidenader Maschinenbau GmbH. From 2012 to 2016 he was responsible as a project manager at Seidenader Maschinenbau GmbH for various projects in the field of semi- and fully automated inspection machines around the globe. 2017 he moved into the sales team and as an area sales manager for inspection machines at Körber Pharma Inspection GmbH (formerly Seidenader) he is now responsible for the sales areas Germany, Russia, and a global sales key account.

  • Thomas Guyon

    Thomas Guyon


    Thomas Guyon obtained a master degree in biomedical science and an MBA in general management. His work in tumor-immunology brought him to study how solid tumors were escaping immune response through secretion of glycans in the extracellular space. Thomas has had the opportunity to work for various types of companies ranging from local SME to large stock-listed companies; in various industries such as life-science, medical device and bioprocessing; and with varying roles : sales, product management and field application scientist. Thomas has a natural attraction for new and innovative technology, which brought him to join the Ovizio adventure.

  • Anke Hossfeld

    Anke Hossfeld

    Merck KGaA

    Anke Hossfeld is Global Product Manager at Merck KGaA in Darmstadt, Germany, responsible for innovation and new product development for the In-Process-Testing in Pharmaceutical Industry. Anke worked as a Technical Assistant in the pharmaceutical field prior to her study of Food Science with a focus on Marketing and Sales. In 2008 she joined the Biotest AG and became International Product Manager for alternative Pyrogen and Mycoplasma testing. In 2011 Anke joined Merck KGaA in Darmstadt as Global Product Manager and has been responsible for different product portfolios including bioburden applications & rapid technologies.

  • Timothy W Hsu

    Timothy W Hsu


    Before becoming the Director of Health Technology Initiatives at AFDO/RAPS Healthcare Products Collaborative, Timothy was a member of the AI Initiative’s Core Strategic Team and has also spent several years working with the GMLP, AIO, and [email protected] teams in varying capacities under the Xavier Health Artificial Intelligence Initiative. Timothy has served across the clinical, operational, and administrative spectrums in healthcare systems ranging from pediatric, academic, research, and community hospitals. His roles in healthcare systems have included work in strategy, planning, perioperative, service line, and population health divisions. Hsu was Product Manager in Clinical Intelligence at Premier Inc., where he was the product owner of Service Line Analytics, Cost Accounting, Patient Analytics, and Clinical Professional Partnerships. He was the market research strategist for healthcare market futures at GBBN Architects. Timothy has a BA in English and Neuroscience from Kenyon College and a master’s in Health Services Administration from Xavier University. He has completed a certificate program in AI & Business Strategy from MIT Sloan and CSAIL.

  • David Hubmayr

    David Hubmayr

    CSL Behring

    David Hubmayr holds a Master degree in Physics from the Technical University Vienna, Austria, Europe as well as continued education certifications in Data Science. David has extensive knowledge and experience in the biopharmaceutical industry stretching from E2E Quality Assurance to R&D with a proven track record of conducting and managing global Quality- and (Digital) Innovation initiatives in both, green-field start-up and commercial operational, environments. In his current role David is member of the R&D Breakthrough Launchpad at CSL Behring, Berne, Switzerland, holding responsibility and leading Digital Transformation initiatives. David is a member of the PDA “CPV-of-the-future” initiative and heading the PDA “Synthetic Data Generation” working group. He is also a member of the “Predictive CSV Risk Assessment” special interest group at ISPE.

  • Anne Grit Klees

    Anne-Grit Klees, PhD

    Merck KGaA

    Dr. Anne-Grit Klees is the lead expert, product & portfolio manager for microbial air samplers at Merck KGaA, Darmstadt, Germany. Her background is microbiology with a graduation at Philipps University in Marburg. She has more than 25 years’ experience with topics around environmental monitoring in the pharmaceutical industry specialized in culture media and viable air samplers.

  • Cleo Kontoravdi

    Cleo Kontoravdi, PhD

    Imperial College London

    Cleo Kontoravdi holds M.Eng. and Ph.D. degrees in Chemical Engineering from Imperial College London. After working as a R&D Scientist at Lonza Biologics she joined the Department of Chemical Engineering at Imperial College London, where she is a Professor of Biological Systems Engineering. Her research is dedicated to understanding the interplay between manufacturing process factors and therapeutic protein quality, including glycosylation and purity. To achieve this her group follows a holistic approach that combines experimentation with model-based design and optimisation tools, which are an excellent vehicle for the industrial implementation of Quality by Design.

  • Kieron McGrath

    Kieron McGrath

    PM Group

    Kieron McGrath RIAI, BA(Hons), Dip Arch, is an architect of 28 years’ experience working in, Pharma, Laboratory and Healthcare projects. Based in Dublin, Ireland he has worked for PM Group for over 14 years. His role is as a Principal Architect (Laboratory SME) and is an Associate Director. He supports all Offices globally for Laboratory Work. He has a proven success in designing new Laboratories around the world. Working with many Pharma Clients and Laboratory types in the US, Europe and Asia brings an extra dimension to his understanding of what the future needs will be in this highly regulated and ever changing space.

  • Aram Montazami

    Aram Montazami


    With twenty years of experience developing products for regulated and healthcare industries, Mr. Aram Montazami, has successfully co-founded Novatek International, Novatek Medical Data Systems, Cognistat and Cognistat Sport. Mr. Montazami plays an active role in management of the Novatek Engineering Team as well as the management of the R&D activities over the last 25 years. With a background in Electrical and Computer Engineering and added expertise in regulated (GAMP, GxP, ISO, ICH, PIC...) and niche market product development, Mr. Montazami has successfully managed the development and commercialization of over 18 software products ranging from thick client-server to Saas solutions worldwide,

  • Markus Prengel

    Markus Prengel

    Merck KGaA

    My name is Markus Prengel living in Darmstadt, Germany. I am holding a Bachelor's in Chemistry and a Master's in Business Chemistry. I joined Merck in 2019 and have been working in Quality for microbiology QC products and now as Global Product Manager - Sterility Testing. I am passionated and excited about the digitalization and automation of the microbiology QC workflows as I am convinced that this will bring the traditional processes on a new level for improved efficiency as well as process safety and compliance.

  • Markus Stuebchen

    Markus Stuebchen

    Hoffmann La-Roche

    Markus Stuebchen started his career in 1996 with the Hoechst AG, Frankfurt, Germany, as a project engineer for DS facilities in the field of e-coli-fermentation, downstream processing and purification. Since 2008, he held positions at F. Hoffmann - La Roche, Basel, Switzerland, as Head of Plant Maintenance and Compounding of Basel's Parenterals Production and Head of Blister Packaging Operations in Kaiseraugst. After joining Global Engineering in 2016 Markus took over the role of the Global Technical Lead Large Molecules Drug Product, which was later moved to Roche's Innovation Technology Group PTI. In this function, he collaborates with global and site functions from engineering, MSAT, procurement and quality as well as equipment suppliers to leverage the implementation of innovative technologies and harmonization of processes across the company's manufacturing sites in Europe and the US. The current focus of his activities is the identification of innovative robotic technologies and deployment of robotic systems in commercial DS and DP manufacturing and packaging as well as the design of Roche's tailored Facility of the Future in his field of responsibility. In this context, Markus leads the Roche Robotics Network Team and engages in the ISPE Special Interest Group Robotics and the Aseptic CoP.

  • Fabian Stutz

    Fabian Stutz


    I am the CEO & Head of Sales with Pharmabotix AG, a company that provides clients with innovative robotics and automation solutions for the pharmaceutical industry. From building an effective team to maintaining a large customer network, I am adept at driving business development while delivering exceptional service to customers with a direct communications approach. I am passionate about trying new ideas and providing honest feedback on feasibility to ensure customer satisfaction.

  • Joeri vanWijngaarden

    Joeri van Wijngaarden, PhD


    Joeri van Wijngaarden is R&D project manager at the innovation lab of Aizon, a cloud company that provides a big data and AI SaaS platform for the Biotech and Pharma industry. In this role he coordinates Aizon's collaborative scientific projects in domains of AI and Biopharma to help accelerate the adoption of AI for pharmaceutical manufacturing and process optimisation. Since 2015 he's been active as a researcher in Life Sciences with a particular interest in artificial and biological intelligence. Joeri holds a Ph.D. in Neurobiology, a Master in Neuroscience and has presented his work at several international conferences, publishing in leading Life Science journals to progress our understanding of complex biological systems.

  • Rudolf Weiss

    Rudolf Weiss

    Staeubli Group

    Rudolf-Michael Weiss started in the senior management at the Stäubli Robotics Division of the STAUBLI Group in October 2020. He took over the global responsibility for robotic/automation business in pharma and medical devices as Global Head of Pharma and as a Member of the Global Division Management Team. After his studies of Mechanical Engineering at University of Stuttgart Rudolf M. Weiss started working at pharma service company Servotech in 1999. From 2001 on, he was working at Groninger where he was responsible as Marketing Director, Senior Project Manager and Regional Sales Director. After further management experiences at FIMA with radial and turbo compressors for petrochemical industry, he decided to go back to pharma and joining Bausch+Ströbel, the global leading company for fill/finish equipment. 2018 he was announced to be Authorized Officer and Director Sales & Marketing. He can draw on 23 years of experience in the field of Pharma Production Processes.

  • David Wolton

    David Wolton


    David has 30+ years of experience in Biologics manufacturing, managing teams, designing equipment, and designing facilities. David specializes in Single-use equipment and mobile robotics, publishing white papers and guides for both the ISPE and Biophorum on these topics. David currently works for Takeda in the global engineering team in Zurich.